The HepGo Assay-ready 3D Liver Spheroid Kit leverages Corning Life Science’s 3D cell culture technology in liver biology and ADME/Tox.
Corning has developed an all-in-one solution for the development of 3D liver models that has been designed to better recapitulate in vivo behaviour. The kit is said to deliver a more physiologically relevant model over traditional 2D models for reliable, accurate drug safety screening and drug efficacy testing.
The kit provides access to 3D PHH liver spheroids, which may improve accuracy and efficiency in various culture applications, including hepatotoxicity assays. It also allows both imaging-based and biochemical assays to be performed on the same plate no transfer required. This streamlines the process, reduces time and cost, and reduces the potential for error, enabling the generation of reliable, accurate, reproducible data.